392 related articles for article (PubMed ID: 30025915)
1. Metformin suppresses growth and adrenocorticotrophic hormone secretion in mouse pituitary corticotroph tumor AtT20 cells.
Jin K; Ruan L; Pu J; Zhong A; Wang F; Tan S; Huang H; Mu J; Yang G
Mol Cell Endocrinol; 2018 Dec; 478():53-61. PubMed ID: 30025915
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
[TBL] [Abstract][Full Text] [Related]
3. Triptolide suppresses growth and hormone secretion in murine pituitary corticotroph tumor cells via NF-kappaB signaling pathway.
Li R; Zhang Z; Wang J; Huang Y; Sun W; Xie R; Hu F; Lei T
Biomed Pharmacother; 2017 Nov; 95():771-779. PubMed ID: 28892788
[TBL] [Abstract][Full Text] [Related]
4. Picropodophyllin inhibits proliferation and survival of diffuse large B-cell lymphoma cells.
Strömberg T; Feng X; Delforoush M; Berglund M; Lin Y; Axelson M; Larsson O; Georgii-Hemming P; Lennartsson J; Enblad G
Med Oncol; 2015 Jul; 32(7):188. PubMed ID: 26021470
[TBL] [Abstract][Full Text] [Related]
5. Lapatinib decreases the ACTH production and proliferation of corticotroph tumor cells.
Asari Y; Kageyama K; Sugiyama A; Kogawa H; Niioka K; Daimon M
Endocr J; 2019 Jun; 66(6):515-522. PubMed ID: 30880293
[TBL] [Abstract][Full Text] [Related]
6. Effects of metformin on cell growth and AMPK activity in pituitary adenoma cell cultures, focusing on the interaction with adenylyl cyclase activating signals.
Faggi L; Giustina A; Tulipano G
Mol Cell Endocrinol; 2018 Jul; 470():60-74. PubMed ID: 28962892
[TBL] [Abstract][Full Text] [Related]
7. Ursolic acid suppresses growth and adrenocorticotrophic hormone secretion in AtT20 cells as a potential agent targeting adrenocorticotrophic hormone-producing pituitary adenoma.
Gong YY; Liu YY; Yu S; Zhu XN; Cao XP; Xiao HP
Mol Med Rep; 2014 Jun; 9(6):2533-9. PubMed ID: 24682498
[TBL] [Abstract][Full Text] [Related]
8. PI3K inhibition by BKM120 results in anti-proliferative effects on corticotroph tumor cells.
Oliveira HA; Bueno AC; Pugliesi RS; da Silva Júnior RMP; de Castro M; Martins CS
J Endocrinol Invest; 2022 May; 45(5):999-1009. PubMed ID: 34988938
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase C delta mediates Pasireotide effects in an ACTH-secreting pituitary tumor cell line.
Gentilin E; Borges De Souza P; Ambrosio MR; Bondanelli M; Gagliardi I; Zatelli MC
J Endocrinol Invest; 2023 Dec; 46(12):2609-2616. PubMed ID: 37233978
[TBL] [Abstract][Full Text] [Related]
10. AT-101 acts as anti-proliferative and hormone suppressive agent in mouse pituitary corticotroph tumor cells.
Yurekli BS; Karaca B; Kisim A; Bozkurt E; Atmaca H; Cetinkalp S; Ozgen G; Yilmaz C; Uzunoglu S; Uslu R; Saygili F
J Endocrinol Invest; 2018 Feb; 41(2):233-240. PubMed ID: 28730425
[TBL] [Abstract][Full Text] [Related]
11. USP8 inhibitor RA-9 reduces ACTH release and cell growth in tumor corticotrophs.
Treppiedi D; Di Muro G; Marra G; Barbieri AM; Mangili F; Catalano R; Serban A; Ferrante E; Locatelli M; Lania AG; Arosio M; Spada A; Peverelli E; Mantovani G
Endocr Relat Cancer; 2021 Jun; 28(8):573-582. PubMed ID: 34086599
[TBL] [Abstract][Full Text] [Related]
12. Targeting the ERK pathway for the treatment of Cushing's disease.
Zhang D; Bergsneider M; Wang MB; Heaney AP
Oncotarget; 2016 Oct; 7(43):69149-69158. PubMed ID: 27708250
[TBL] [Abstract][Full Text] [Related]
13. Growth suppression of mouse pituitary corticotroph tumor AtT20 cells by curcumin: a model for treating Cushing's disease.
Bangaru ML; Woodliff J; Raff H; Kansra S
PLoS One; 2010 Apr; 5(4):e9893. PubMed ID: 20405005
[TBL] [Abstract][Full Text] [Related]
14. Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in in vitro and in vivo xenograft models.
Zi FM; He JS; Li Y; Wu C; Yang L; Yang Y; Wang LJ; He DH; Zhao Y; Wu WJ; Zheng GF; Han XY; Huang H; Yi Q; Cai Z
Cancer Lett; 2015 Jan; 356(2 Pt B):443-53. PubMed ID: 25305450
[TBL] [Abstract][Full Text] [Related]
15. The expression of glucocorticoid and mineralocorticoid receptors in pituitary tumors causing Cushing's disease and silent corticotroph tumors.
Kober P; Rusetska N; Mossakowska BJ; Maksymowicz M; Pękul M; Zieliński G; Styk A; Kunicki J; Działach Ł; Witek P; Bujko M
Front Endocrinol (Lausanne); 2023; 14():1124646. PubMed ID: 37065760
[TBL] [Abstract][Full Text] [Related]
16. Targeting Corticotroph HDAC and PI3-Kinase in Cushing Disease.
Zhang D; Damoiseaux R; Babayan L; Rivera-Meza EK; Yang Y; Bergsneider M; Wang MB; Yong WH; Kelly K; Heaney AP
J Clin Endocrinol Metab; 2021 Jan; 106(1):e232-e246. PubMed ID: 33000123
[TBL] [Abstract][Full Text] [Related]
17. Metformin inhibits cell proliferation and ACTH secretion in AtT20 cells via regulating the MAPK pathway.
Sun Y; Cheng J; Nie D; Fang Q; Li C; Zhang Y
Mol Cell Endocrinol; 2024 Mar; 582():112140. PubMed ID: 38147953
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin analogs regulate tumor corticotrophs growth by reducing ERK1/2 activity.
Treppiedi D; Giardino E; Catalano R; Mangili F; Vercesi P; Sala E; Locatelli M; Arosio M; Spada A; Mantovani G; Peverelli E
Mol Cell Endocrinol; 2019 Mar; 483():31-38. PubMed ID: 30611770
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor type-I receptor-dependent phosphorylation of extracellular signal-regulated kinase 1/2 but not Akt (protein kinase B) can be induced by picropodophyllin.
Vasilcanu R; Vasilcanu D; Sehat B; Yin S; Girnita A; Axelson M; Girnita L
Mol Pharmacol; 2008 Mar; 73(3):930-9. PubMed ID: 18070930
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin regulates ACTH secretion and the HPAA in an AMPK-dependent manner in pituitary corticotroph cells.
Chen M; Wang Z; Zhan M; Liu R; Nie A; Wang J; Ning G; Ma Q
Mol Cell Endocrinol; 2014 Mar; 383(1-2):118-25. PubMed ID: 24361598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
